106 related articles for article (PubMed ID: 30102196)
1. Body Mass Index as a Prognostic Marker in Glioblastoma Multiforme: A Clinical Outcome.
Potharaju M; Mangaleswaran B; Mathavan A; John R; Thamburaj V; Ghosh S; Ganesh S; Kalvakonda C; Loganathan M; Bapu S; Devi R; Verma RS
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):204-209. PubMed ID: 30102196
[TBL] [Abstract][Full Text] [Related]
2. Body mass index as an independent prognostic factor in glioblastoma.
Valente Aguiar P; Carvalho B; Vaz R; Linhares P
Cancer Causes Control; 2021 Apr; 32(4):327-336. PubMed ID: 33447892
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes of giant cell glioblastoma: institutional experience in the management of 20 patients.
Oh T; Rutkowski MJ; Safaee M; Sun MZ; Sayegh ET; Bloch O; Tihan T; Parsa AT
J Clin Neurosci; 2014 Dec; 21(12):2129-34. PubMed ID: 25037316
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
[TBL] [Abstract][Full Text] [Related]
8. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
Seidlitz A; Siepmann T; Löck S; Juratli T; Baumann M; Krause M
Radiat Oncol; 2015 Aug; 10():172. PubMed ID: 26276734
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
Kim BS; Seol HJ; Nam DH; Park CK; Kim IH; Kim TM; Kim JH; Cho YH; Yoon SM; Chang JH; Kang SG; Kim EH; Suh CO; Jung TY; Lee KH; Kim CY; Kim IA; Hong CK; Yoo H; Kim JH; Kang SH; Kang MK; Kim EY; Kim SH; Chung DS; Hwang SC; Song JH; Cho SJ; Lee SI; Lee YS; Ahn KJ; Kim SH; Lim DH; Gwak HS; Lee SH; Hong YK
Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme.
Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A
Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031
[TBL] [Abstract][Full Text] [Related]
13. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of patients with multifocal glioblastoma: a case-control study.
Patil CG; Yi A; Elramsisy A; Hu J; Mukherjee D; Irvin DK; Yu JS; Bannykh SI; Black KL; Nuño M
J Neurosurg; 2012 Oct; 117(4):705-11. PubMed ID: 22920963
[TBL] [Abstract][Full Text] [Related]
15. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar glioblastoma multiforme: a retrospective study of 28 patients at a single institution.
Yang S; Liu J; Wang T; Li X; You C
Int J Neurosci; 2013 Oct; 123(10):691-7. PubMed ID: 23550813
[TBL] [Abstract][Full Text] [Related]
17. Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era.
Ortega A; Sarmiento JM; Ly D; Nuño M; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2016 Feb; 24():105-11. PubMed ID: 26671314
[TBL] [Abstract][Full Text] [Related]
18. Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation.
Molitoris JK; Rao YJ; Patel RA; Kane LT; Badiyan SN; Gittleman H; Barnholtz-Sloan JS; Bentzen SM; Kruser TJ; Huang J; Mehta MP
J Neurooncol; 2017 Sep; 134(2):331-338. PubMed ID: 28643151
[TBL] [Abstract][Full Text] [Related]
19. Primary Spinal Cord Glioblastoma Multiforme: A Retrospective Study of Patients at a Single Institution.
Cheng X; Lou S; Huang S; Chen H; Liu J
World Neurosurg; 2017 Oct; 106():113-119. PubMed ID: 28377242
[TBL] [Abstract][Full Text] [Related]
20. Body mass index and mortality in patients with gastric cancer: a large cohort study.
Lee JH; Park B; Joo J; Kook MC; Kim YI; Lee JY; Kim CG; Choi IJ; Eom BW; Yoon HM; Ryu KW; Kim YW; Cho SJ
Gastric Cancer; 2018 Nov; 21(6):913-924. PubMed ID: 29651648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
